CELLTRION WILL Rise Next week !CELLTRION WILL Rise Next week
BUY Or Keep it in the portfolio
Target 282000 KRW
2.886573USD
411.38 MUSD
1.67 BUSD
143.28 M
About Celltrion, Inc.
Sector
Industry
CEO
Wu-Sung Ki
Website
Headquarters
Inchon
Employees (FY)
2.53 K
Founded
1991
ISIN
KR7068270008
FIGI
BBG000L3NN58
Celltrion, Inc. engages in the development, manufacture and distribution of pharmaceuticals. It operates through the Biopharmaceuticals, Chemical Drugs and Others businesses. Its products include remsima and biosimilars. The company was founded on February 27, 1991 and is headquartered in Incheon, South Korea.
Celltrion Rising Wedge PeriodClearly Celltrion chart is forming rising wedge period. As long as the price is in the trend line the trend is in bullish. But between 50%-70% area is the key that market may shift to other direction.
If price bounce at support line with high volume, price would like to go 370000 won. Probably pri
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where CONIF is featured.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Celltrion, Inc. stocks are traded under the ticker CONIF.
Celltrion, Inc. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Celltrion, Inc. has a max estimate of 216.300000 USD and a min estimate of 124.012000 USD.
CONIF earnings for the last quarter are 0.80 USD per share, whereas the estimation was 0.67 USD resulting in a 19.04% surprise. The estimated earnings for the next quarter are 0.03 USD per share. See more details about Celltrion, Inc. earnings.
Celltrion, Inc. revenue for the last quarter amounts to 495.49 M USD despite the estimated figure of 460.92 M USD. In the next quarter revenue is expected to reach 386.63 M USD.
Yes, you can track Celltrion, Inc. financials in yearly and quarterly reports right on TradingView.
CONIF net income for the last quarter is 809.40 K USD, while the quarter before that showed 163.49 M USD of net income which accounts for −99.50% change. Track more Celltrion, Inc. financial stats to get the full picture.
Yes, CONIF dividends are paid annually. The last dividend per share was 0.38 USD. As of today, Dividend Yield (TTM)% is 0.28%. Tracking Celltrion, Inc. dividends might help you take more informed decisions.
Celltrion, Inc. dividend yield was 0.25% in 2023, and payout ratio reached 13.30%. The year before the numbers were 0.22% and 9.78% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, CONIF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Celltrion, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 2.53 K employees. See our rating of the largest employees — is Celltrion, Inc. on this list?
We've gathered analysts' opinions on Celltrion, Inc. future price: according to them, CONIF price has a max estimate of 216.30 USD and a min estimate of 124.01 USD. Read a more detailed Celltrion, Inc. forecast: see what analysts think of Celltrion, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Celltrion, Inc. EBITDA is 688.98 M USD, and current EBITDA margin is 41.22%. See more stats in Celltrion, Inc. financial statements.